Dobutamine vs. milrinone in subarachnoid hemorrhage related heart failure

被引：0
|
作者：
Naidech, A [1 ]
Kreier, KT [1 ]
Ostapkovich, N [1 ]
Parra, A [1 ]
Fitzsimmons, BF [1 ]
Connolly, ES [1 ]
Mayer, SA [1 ]
Commichau, C [1 ]
机构：
[1] Columbia U, New York, NY USA
来源：
CRITICAL CARE MEDICINE | 2003年 / 31卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
323
引用
收藏
页码：A89 / A89
页数：1
相关论文
共 50 条
  • [1] Dobutamine versus milrinone after subarachnoid hemorrhage
    Naidech, A
    Du, YL
    Kreiter, KT
    Parra, A
    Fitzsimmons, BF
    Lavine, SD
    Connolly, ES
    Mayer, SA
    Commichau, C
    [J]. NEUROSURGERY, 2005, 56 (01) : 21 - 26
  • [2] Dobutamine versus milrinone after subarachnoid hemorrhage - Comments
    Dumont, AS
    Kassell, NF
    Findlay, JM
    Macdonald, RL
    [J]. NEUROSURGERY, 2005, 56 (01) : 26 - 27
  • [3] MILRINONE VERSUS DOBUTAMINE IN CONGESTIVE HEART-FAILURE
    FITZPATRICK, PG
    VAKIENER, AR
    BAGGS, JG
    MURPHY, S
    HOOD, WB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (02) : 440 - 440
  • [4] MULTICENTER COMPARISON OF MILRINONE AND DOBUTAMINE IN CONGESTIVE HEART-FAILURE
    KONSTAM, MA
    BENOTTI, JR
    BIDDLE, T
    CREAGER, MA
    FAXON, DP
    FIRTH, BG
    FITZPATRICK, PG
    KREBS, C
    [J]. CIRCULATION, 1985, 72 (04) : 201 - 201
  • [5] Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients
    Milwidsky, Assi
    Frydman, Shir
    Laufer-Perl, Michal
    Sadeh, Ben
    Sapir, Orly
    Granot, Yoav
    Hochstadt, Aviram
    Korotetski, Liuba
    Ketchker, Liora
    Topilsky, Yan
    Banai, Shmuel
    Havakuk, Ofer
    [J]. ESC HEART FAILURE, 2022, 9 (02): : 1487 - 1491
  • [6] Comparative effectiveness of milrinone vs dobutamine on out-of-hospital mortality in patients with acute decompensated heart failure
    King, Jordan
    Sainski-Nguyen, Amy
    Shah, Rashmee
    Munger, Mark
    Biskupiak, Joseph
    Bress, Adam
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E262 - E262
  • [7] Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE
    Mebazaa, Alexandre
    Nieminen, Markku S.
    Filippatos, Gerasimos S.
    Cleland, John G.
    Salon, Jeffrey E.
    Thakkar, Roopal
    Padley, Robert J.
    Huang, Bidan
    Cohen-Solal, Alain
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (03) : 304 - 311
  • [8] Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes
    Bayram, M
    De Luca, L
    Massie, MB
    Gheorghiade, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (6A): : 47G - 58G
  • [9] ADDITIVE EFFECTS OF MILRINONE AND DOBUTAMINE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    MEISSNER, A
    HERRMANN, G
    GERDESMEYER, L
    SIMON, R
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1992, 81 (05): : 266 - 271
  • [10] Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol
    Lowes, BD
    Tsvetkova, L
    Eichhorn, EJ
    Gilbert, EM
    Bristow, MR
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 81 (2-3) : 141 - 149
12345